Long-Term Thinking and Behavior After Deep Brain Stimulation in Parkinson's Disease
Follows people with Parkinson's disease for 5 years after deep brain stimulation.
Key facts
- Who runs it
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Where
- Milan, ItalySee the site
- Trial code
- Registry title
- Long-Term Behavioral and Cognitive Outcomes of Deep Brain Stimulation in Patients With Parkinson's Disease
- Status
- Recruiting
- People taking part
- 52 people, planned
- Started
- 13 Dec 2021
- Expected to end
- 15 Dec 2032
- Type of study
- Observational, 2 groups
- Treatments tested
- Clinical examinations and clinical scales administration
- Record updated
- 26 March 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Parkinson's disease. Some are candidates for deep brain stimulation of the subthalamic nucleus, and others are on standard medicine treatment.
- Age
- 18 to 70 years
- Sex
- All sexes can join.
- Disease stage
- Parkinson's disease.
- Earlier treatment
- One group is planned for deep brain stimulation of the subthalamic nucleus. The other group takes standard medicine treatment.
Main reasons for not taking part
- People who cannot complete the study assessments cannot join.
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Parkinson's disease patients candidates for DBS of the subthalamic nucleus
- Parkinson's disease patients with best medical treatment
Who cannot take part
- patients unable to complete study assessments
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in Italy
- Fondazione IRCCS Cà Granda Ospedale Maggiore PoliclinicoMilan, ItalyContact: Eleonora Zirone, DrTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to evaluate the long-term effect of DBS-STN on cognitive and behavioral outcomes in Parkinson's disease (PD) patients.
Read full original descriptionShow less
PD patients will be assessed over time using tests, questionnaires and standardized clinical scales. An initial assessment (T0) and annual follow-up assessments will be carried out for 5 years.
Researchers will compare data collected from patients with DBS versus patients with best medical therapy.
The 2 groups in the trial
- PD - undergone DBS
Patients with Parkinson's disease treated with DBS of the subthalamic nucleus
Treatment: Clinical examinations and clinical scales administration
- PD - not undergone DBS
Patients with Parkinson's disease not treated with DBS
Treatment: Clinical examinations and clinical scales administration
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Long-Term Behavioral and Cognitive Outcomes of Deep Brain Stimulation in Patients With Parkinson's Disease
- Plain-language title
- Long-Term Thinking and Behavior After Deep Brain Stimulation in Parkinson's DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06329726, who can take part
- Record updated
- 26 March 2024